Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion - The Wall Street Journal
wsj.comSubmitted by thewallstreetjournal7221 in business
Deal expands pharmaceutical company’s portfolio of cancer drugs
Submitted by thewallstreetjournal7221 in business
Deal expands pharmaceutical company’s portfolio of cancer drugs